NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Rapid Micro Biosystems, Inc. (RPID) Stock Analysis

Rapid Micro Biosystems, Inc. (RPID) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

RPID

$0.82

+$0.04 (+5.77%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RPID with… →

RPID Key Statistics

As of Oct 21, 2026
Trading
Open
$0.78
Previous Close
$0.77
Day's Range
0.76–0.83
52-Week Range
0.76–4.94
Volume
79.62K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.51
Valuation
Market Cap
$40.94M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.16
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.11
Financials (FY)
Revenue (FY)
$33.59M+19.74%
Net Income (FY)
−$47.12M
Profit marginThe share of revenue left as profit after all costs and taxes.
−145.55%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
45.66M
1-Year Return
−72.14%
Dividend and dates
Earnings Date
November 6, 2026estimated
Avg Volume
253.38K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, RPID closed at $0.82, −72.14% over 1 year.

Rapid Micro Biosystems, Inc. (RPID) has a market capitalization of $40.94M.

In fiscal 2025, RPID reported revenue of $33.59M.

RPID Stock Return by Calendar Year

Rapid Micro Biosystems, Inc. (RPID) return since Jul 2021: what $10,000 became

1 year
$10,000 $2,786
−72.14%
5 years
$10,000 $409
−95.91%
Since Jul 2021
$10,000 $381
−96.19%

If you had invested $10,000 in Rapid Micro Biosystems, Inc. (RPID) at the close on July 15, 2021, the earliest close on record here, it would have been worth $381 at the close on October 21, 2026: −96.19% in total, −46.21% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−71.86%
2025+222.22%
2024+21.62%
2023−34.51%
2022−89.38%
2021 (partial year)−50.28%

As of October 21, 2026.

RPID Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$33.59M−$47.12M−140.3%
2024$28.05M−$46.89M−167.2%
2023$22.52M−$52.47M−233.0%
2022$17.13M−$60.81M−354.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$33.59M$1.05M−$47.39M−$47.12M−140.3%
2024$28.05M−$109.00K−$49.92M−$46.89M−167.2%
2023$22.52M−$5.49M−$56.56M−$52.47M−233.0%
2022$17.13M−$8.54M−$63.22M−$60.81M−354.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

RPID Valuation vs Medical Devices Median

Median of 145 stocks
MetricRPIDMedical Devices medianvs median
P/S ratio1.162.5354% below
Profit margin−145.55%−14.78%130.8 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 16 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Rapid Micro Biosystems, Inc. (RPID) carries a market capitalisation of $40.94M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 171 employees.

The 52-week range on file runs from $0.76 to $4.94. The most recent close on file for RPID is $0.82, dated October 21, 2026. That is +$0.04 (+5.77%) against the previous close. The latest close sits 7.39% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $33.59M. Against the prior fiscal year total of $28.05M, that is a change of +19.74%. The same year closed with a net loss of $47.12M. Profit margin runs at −145.55%. That is 130.8 percentage points below the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −1.11.

Across the 4 fiscal years on file, revenue moves from $17.13M in 2022 to $33.59M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 1.16 times revenue. On price-to-sales that is 53.99% below the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Over the trailing twelve months the total return is −72.14%. Measured over 5 years, that is −47.23% a year compounded. Beta against the wider market is reported at 1.51. Daily returns over the trailing 5 years annualize to a volatility of 86.17%.

Growth & Income

No dividend is on file for RPID.

So far in 2026 the total return is −71.86%. The strongest complete calendar year on file is 2025 at +222.22%; the weakest is 2022 at −89.38%. Of the 4 complete calendar years on file, 2 finished higher.

Peer Comparison

Rapid Micro Biosystems, Inc. (RPID) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Rapid Micro Biosystems, Inc. RPID $40.94M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Rapid Micro Biosystems, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Visit website →